Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TRANSENSE TECHNOLOGIES PLC Director's Dealing 2014

Dec 30, 2014

7985_dirs_2014-12-30_de411618-e5aa-4abd-8ed8-ca963849b0a5.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9144A

Transense Technologies PLC

30 December 2014

Transense Technologies PLC

(the "Company")

Director Dealing

On 29 December 2014 the Company was notified that the non-beneficial holding of David Kleeman, Non-Executive Deputy Chairman, has reduced by 537,775 ordinary shares of 1p each ("Shares").  The beneficial holder of these shares sold 327,775 Shares and 210,000 Shares, at 3p in both instances, on 22 and 23 December 2014 respectively.

On 22 December 2014, the Company announced that David Kleeman will be retiring from the Board as Deputy Chairman and as a Non-Executive Director with effect from 31 December 2014.

Following the above transactions, the beneficial holding of David Kleeman in the Company remains unchanged at 3,128,891 Ordinary Shares and his non-beneficial interest is 373,267 Ordinary Shares. In aggregate, these interests amount to 3,502,158 Ordinary Shares, representing 1.18% of the Company's total voting rights. 

For more information, please contact:

Transense Technologies plc

Graham Storey, Chief Executive

David Ford, Company Secretary
Tel: +44 (0)1869 238 380
N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell, Alex Wright, Thomas Smale
Tel: +44 (0)20 7496 3000
Newgate Threadneedle

Tim Thompson, Robyn McConnachie
Tel: +44 (0)20 7653 9850

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFILFLLIVIS